The Food and Drug Administration (FDA) has approved the very first artificial intelligence (AI) computer that monitors a patient’s vitals to help forecast sudden death up to six hours before the grim reaper shows up.
Excel Medical, a medical device data company in Florida, developed the deep learning algorithm called WAVE Clinical Platform for the eradication of unexpected hospital deaths.
WAVE automatically calculates the risk of the patient through subtle changes in vitals, which provides hospital staff with critical information of when the patient is expected to kick the bucket. The algorithm monitors the patient on a continuous basis, a task that is very challenging for hospitals, as the demographic crisis strains the U.S. healthcare system.
Stephen McBride of Mauldin Economics describes the situation:
“Few investors understand the magnitude of the looming demographic crisis and its ramifications. The first Baby Boomers turned 70 last year. At the same time, the US fertility rate is at its lowest point since records began in 1909. This disastrous combination means by 2030, those aged 65 and older will make up over 20% of the population.”
Read more: Death Panels Next? FDA Approves A.I. Model That Predicts Your Chance Of 'Sudden Expiration'